Medical diagnostics co DiabetOmics raises $5M from Ventureast, Shantha founder
US-headquartered DiabetOmics Inc, a growth-stage medical diagnostics company with India operations, has raised its Series C round of funding worth $4 million from Ventureast to drive manufacturing and commercialisation in India, as per a company release. It has also raised an additional $1 million from KI Varaprasad Reddy, the founder of Shantha Biotechnics, who sold his company to Sanofi a few years ago. He will take over the post of chairman at DiabetOmics and will head the India unit once it is set up.
...